Novel pediatric delivery systems for second-line anti-tuberculosis medications: a case study

Int J Tuberc Lung Dis. 2013 Sep;17(9):1239-41. doi: 10.5588/ijtld.13.0196. Epub 2013 Jul 3.

Abstract

Tens of thousands of children are sick with multidrug-resistant forms of tuberculosis (MDR-TB), but there are limited child-friendly delivery systems for second-line medications. This case study presents the development of a granular dosing spoon pediatric delivery system for para-aminosalicylic acid. This product is the first of its kind for MDR-TB and could serve as a model for the development of other urgently needed pediatric delivery systems for second-line anti-tuberculosis drugs.

MeSH terms

  • Administration, Oral
  • Age Factors
  • Aminosalicylic Acid / administration & dosage*
  • Antitubercular Agents / administration & dosage*
  • Chemistry, Pharmaceutical
  • Child
  • Dosage Forms
  • Drug Delivery Systems* / instrumentation
  • Equipment Design
  • Humans
  • Technology, Pharmaceutical / methods
  • Tuberculosis, Multidrug-Resistant / diagnosis
  • Tuberculosis, Multidrug-Resistant / drug therapy*

Substances

  • Antitubercular Agents
  • Dosage Forms
  • Aminosalicylic Acid